Anticardiolipin and anti-β2glycoprotein I immunoassays in the diagnosis of antiphospholipid syndrome

Clinical and Experimental Rheumatology

Volumn 16, Issue 4, 1998, Pages 396-402

  Tincani, A ^a,d   Balestrieri, G ^a   Spatola, L ^a   Cinquini, M ^a   Meroni, P L ^b   Roubey, R A S ^c  

^a UNIVERSITY OF BRESCIA   (Italy)

^b IRCCS   (Italy)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d Ospedale Civile di Brescia   (Italy)

Author keywords

Anti 2 glycoprotein I antibodies; Anticardiolipin antibodies; Antiphospholipid antibodies; Antiphospholipid syndrome; Beta 2 glycoprotein I; Lupus anticoagulant; Systemic lupus erythematosus

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; BLOOD CLOTTING TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS WASTAGE; HUMAN; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOSIS;

ANIMALS; ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; GLYCOPROTEINS; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; SENSITIVITY AND SPECIFICITY;

EID: 0031873626     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (103)

1. HARRIS EN, GHARAVI AE, BOEY ML, et al.: Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; 2: 1211-4.
2. LOIZOU S, MCCREA JD, RUDGE AC, REYNOLDS R, BOYLE CC, HARRIS EN: Measurement of anticardiolipin antibodies by an enzyme linked immunosorbent assay (ELISA): Standardization and quantitation of results. Clin Exp Immunol 1985; 62: 738-45.
3. PANGBORN MC: Isolation and purification of a serologically active phospholipid from beef heart. J Biol Chem 1942; 143: 247-56.
4. MORE JE, LUTZ WB: The natural history of systemic lupus erythematosus: An approach to its study through chronic biologic false positive reactors. J Chronic Dis 1955; 1: 297-316.
5. LAURELL AB, NILSSON IM: Hypergammaglobulinemia, circulating anticoagulant, and biologic false positive Wassermann reaction. J Lab Clin Med 1957; 49: 694-707.
6. LEE SL, SANDERS M: A disorder of blood coagulation in systemic lupus erythematosus. J Clin Invest 1955, 34: 1814-22.
7. NILSSON IM, ASTEDT B, HEDNER U: Intrauterine death and circulating anticoagulant "antithromboplastin". Acta Med Scand 1975; 197: 153-9.
8. BOWIE EJ, THOMPSON JH JR, PASCUZZI CA JR: Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. J Lab Clin Med 1963; 62: 416-30.
9. ALARCON-SEGOVIA D, OSMUNDSON PJ: Peripheral vascular syndromes associated with systemic lupus erythematosus. Ann Intern Med 1965; 62: 416-30.
10. ALAGILLE D, CROSNIER J, SOULIER JP: Anticoagulant circulant à activité antithromboplastique. Rev Franç et Clin Biol 1956; 1: 335-45.
11. SOULIER JP, BOFFA MC: Avortements à repetition, thromboses et anticoagulant circulant antithromboplastine. Nouv Presse Med 1980; 9: 859-64.
12. HUGHES GRV: Thrombosis, abortion, cerebral disease and lupus anticoagulant. BMJ 1983; 287: 1088-9.
13. ASHERSON RA, KHAMASHTA MA, ORDIROS J: The "primary" antiphospholipid syndrome: Major clinical and serological features. Medicine 1989; 68: 366-74.
14. ALARCON-SEGOVIA D, SANCHEZ-GUERRERO J: Primary antiphospholipid syndrome. J Rheumatol 1989; 16: 482-4.
15. ROUBEY RAS: Antiphospholipid antibody syndrome. In KOOPMAN WJ et al. (Eds.): Arthritis and Allied Conditions: A Textbook of Rheumatology. 13th ed., Philadelphia, 1997: 1393-406.
16. ALARCON-SEGOVIA D, DELEZE M, ORIA CV, et al.: Antiphospholipid antibodies and the antiphospholipid syndrome in the systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine 1989; 68: 335-65.
17. HUGHES GRV: The anticardiolipin syndrome. Clin Exp Rheumatol 1985; 3: 285-6.
18. HARRIS EN, GHARAVI AE, LOIZOU S, et al.: Cross-reactivity of antiphospholipid antibodies. J Clin Lab Immunol 1985; 16: 1-6.
19. THIAGARJAN P, SHAPIRO SS, DE MARCO L: Monoclonal immunoglogulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of lupus anticoagulant. J Clin Invest 1980; 66: 397-405.
20. MCNEIL HP, CHESTERMAN CN, KRILIS SA: Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 1991; 49: 193-280.
21. HARRIS EN, GHARAVI AE, WASLEY GD, HUGHES GRV: Use of enzyme linked immunosorbent assay and of inhibition studies to distinguish between anticardiolipin antibodies from patients with syphilis or autoimmune disorders. J Infect Dis 1988; 157: 23-31.
22. JOHANSSON EA, LASSUS A: The occurrence of circulating anticoagulants in patient with syphilitic and biologically false positive antilipoidal antibodies. Ann Clin Res 1974; 6: 105-108.
23. HARRIS EN, GHARAVI AE, PATEL SP, HUGHES GRV: Evaluation of the anticardiolipin antibody test: Report of a standardization workshop held in April 1986. Clin Exp Immunol 1987; 68: 215-22.
24. GALLI M, CONFURIUS P, MAASSEN C, et al.: Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335: 1544-7.
25. 2glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120-4.
26. MATSUURA E, IGARASHI Y, FUJIMOTO M, ICHIKAWA K, KOIKE T: Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990; 336: 177-8.
27. 2 globulin des humanserum. Naturwissenschatten 1961; 48: 719-24.
28. REID KBM, BENTLEY DR, CAMPBELL RD: Complement system proteins which interact with C3b or C4b: A superfamily of structurally related proteins. Immunol Today 1986; 7: 230-4.
29. 2-glycoprotein I (apolipoprotein H) interaction with phospholipid vesicles. Int J Biochem 1984; 16: 511-5.
30. 2 glycoprotein I. Biochem Biophys Acta 1986; 884: 142-9.
31. 2-glycoprotein I: A plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood 1985; 66: 1086-91.
32. 2 glycoprotein I (apoH) inhibits the release reaction of human platelets during ADP-induced aggregation. Atherosclerosis 1987; 63:109-14.
33. CHONN A, SEMPLE SC, CULLIS PR: Beta 2 glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of "non self" particles. J Biol Chem 1995; 270: 25845-9.
34. CAI G, SATHOH T, HOSHI H: Purification and characterization of an endothelial cell-viability maintaining factor from fetal bovine serum. Biochim Biophys Acta 1995; 1269/1: 13-8.
35. ALLEGRI F, BALESTIERI G, CATTANEO R, et al.: The plasma cofactor and anticardiolipin antibodies. Clin Exp Rheumatol 1990; 8: 613-4 (letter).
36. 2-glycoprotein I: Analysis of anticardiolipin antibodies in leprosy. Lupus 1994; 3: 515-8.
37. LOIZOU S, CAZABON JK, WALPORT MJ, TAIT D, SO AK: Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 103-8.
38. 2 glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994; 179: 457-62.
39. 2-glycoprotein I as antigen. J Immunol Methods 1991; 143: 223-9.
40. 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 1992; 93: 181-6.
41. 2-glycoprotein I: Comparison with a standard anticardiolipin assay. Arthritis Rheum 1998; 37: S298 (abstract).
42. 2-glycoprotein I: A marker of antiphospholipid syndrome? Lupus 1995; 4: 122-30.
43. 2-Glycoprotein I in the absence of phospholipid: Importance of antigen density and bivalent binding. J Immunol 1995; 154: 954-60.
44. TINCANI A, SPATOLA L, PRATI E, et al.: The Anti Beta 2 Glycoprotein I activity in human antiphospholipid syndrome sera is due to monoreactive low affinity autoantibodies directed to epitopes located on native Beta 2 Glycoprotein I and preserved during species' evolution. J Immunol 1996; 157: 5732-8.
45. ROUBEY RAS: Immunology of the antiphospholipid antibody syndrome. Arthritis Rheum 1996; 39: 1444-54.
46. 2-glycoprotein I in patients with primary antiphospholipid syndrome. J Rheumatol 1995; 22: 1894-8.
47. 2glycoprotein I than with antiphospholipid antibodies. J Rheumatol 1995; 22: 1899-906.
48. 2 glycoprotein I. Ann Biol Clin 1994; 52: 381-5.
49. 2GPI binding to phospholipids. J Clin Invest 1997; 99: 2260-8.
50. 2-glycoprotein I complexes to lipid membranes. Biochemistry 1996; 35: 13833-42.
51. 2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules. Clin Exp Rheumatol 1995; 13: 179-85.
52. SIMANTOV R, LA SALA JM, LO SK, et al.: Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest 1995; 96: 2211-9.
53. DEL PAPA N, GUIDALI L, SALA A, et al.: Endothelial cells as targets for antiphospholipid antibodies. Arthritis Rheum 1997; 40: 551-61.
54. MANFREDI AA, ROVERE P, GALATI G, et al.: Apoptotic cell clearance in Systemic Lupus Erythematosus: I Opsonization by antiphospholipid antibodies. Arthritis Rheum 1998; 41: 205-14.
55. 2-glycoprotein I. Arthritis Rheum 1998; 41: 215-23.
56. GHARAVI AE, MELLORS RC, ELKON KB: IgG anticardiolipin antibodies in murine lupus. Clin Exp Immunol 1989; 78: 233-8.
57. HASHIMOTO Y, KAWAMURA M, ICHICAWA KK, et al.: Anticardiolipin antibodies in NZW x BXSB F1 mice. J Immunol 1992; 149: 1063-8.
58. CABIEDES J, CABRAL AR, ALARCON-RIQUELME M, ALARCON-SEGOVIA D: Overt and hidden aCL and antiphosphatidylcholine antibodies in BALB/c and NZB mice. Lupus 1994; 3 (Suppl. 4): 340.
59. CABRAL AR, CABIEDES J, ALARCON-SEGOVIA D: Hemolytic anemia related to an IgM autoantibody to phosphatidylcholine that binds in vitro to stored and bromeline-treated erythrocyte. J Autoimmunity 1990; 3: 773-87.
60. BRANCH DW, DUDLEY DJ, MITCHELL MD et al.: Immunoglobulin G fraction from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: A model for autoimmune fetal loss. Am J Obstet Gynecol 1990; 163: 210-6.
61. BLANK M, COHEN J, TODER V, SHOENFELD Y: Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyplonal anti-cardiolipin antibodies. Proc Natl Acad Sci USA 1991; 88: 3069-73.
62. PIONA A, LA ROSA L, TINCANI A, et al.: Effect of passive transfer of anticardiolipin antibodies on pregnancy outcome in BALB/c mice. Scand J Immunol 1995; 42: 27-32.
63. BLANK M, TINCANI A, SHOENFELD Y: Induction of experimental anti-phospholipid syndrome in naive mice with purified IgG antiphosphatidylserine antibodies. J Rheumatol 1994; 21: 100-4.
64. VOGT E, AH-KAU NG, ROTE NS: A model for the antiphospholipid antibody syndrome: Monoclonal antiphosphatidylserine antibody induces intrauterine growth restriction in mice. Am J Obstet Gynecol 1996; 174: 700-7.
65. SAMMARITANO LR, LOCKSHIN MD, GHARAVI AE: Antiphospholipid antibodies differ in antiphospholipid cofactor requirement. Lupus 1992; 1: 51-56.
66. IKEMATSU W, FULUNG L, LAROSA L, et al.: Human anticardiolipin monoclonal autoantibodies cause placental necrosis and fetal loss in BALB/c mice. Arthritis Rheum (in press).
67. 2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental anti-phospholipid syndrome. Circulation, in press.
68. 2GPI antibodies in pregnant naive BALB/c mice (submitted).
69. KATSURAGAWA H, ROTE N, INOUE T, NARUKAWA S, KANZAKI H, MORI T: Monoclonal antiphosphatidylserine antibody reactivity against human first-trimester placental trophoblasts. Am J Ostet Gynecol 1995; 172: 1592-7.
70. RAND JH, WU X, ANDREE H, et al.: Pregnancy loss in the antiphospholipid antibody syndrome: A possible thrombogenic mechanism. N Engl J Med 1997; 337: 154-60.
71. PIERANGELI SS, HARRIS EN: Antiphospholipid antibodies in an in vivo thrombosis model mice. Lupus 1994; 3: 247-51.
72. PIERANGELI SS, LIU XW, BARKER JEL ANDERSON G, HARRIS EN: Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome. Thromb Haemost 1995; 74: 1361-7.
73. OLEE T, PIERANGELI SS, HADLEY HH, et al.: A monoclonal IgG anticardiolipin antibody from a patient with the antiphospholpid syndrome is thrombogenic in mice. Proc Natl Acad Sci USA 1996; 93: 8606-11.
74. RADIC MZ, IBRAHIM SM, RAUCH J, CAMPER SA, WEIGERT M: Constitutive secretion of transgene encoded IgG2b autoantibodies leads to symptoms of autoimmune disease. J Immunol 1995; 155: 3213-22.
75. BAKIMER R, FISHMAN P, BLANK M, SREDNI B, DJALDETTI M, SHOENFELD Y: Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H3). J Clin Invest 1992; 89: 1558-63.
76. 2 glycoprotein I or anticardiolipin antibodies alone. Clin Exp Immunol 1993; 93: 269-72.
77. PIERANGELI SS, LIU SW, ANDERSON G, BARKER JH, HARRIS EN: Thrombogenic properties of murine anti-cardiolipin antibodies induced by beta 2-glycoprotein I and human immunoglobulin G antiphospholipid antibodies. Circulation 1996; 94: 1746-51.
78. 2-glycoprotein I (apolipoprotein H). J Clin Invest 1992; 90: 1105-9.
79. COTE SA, BREY RL, TRALE JM: Autoimmune neurological disease is accelerated in MRL/ ++ mice after apolipoprotein H (Apo H) immunization. Lupus 1994; 3: 97 (abstract).
80. BLANK M, FADEN D, TINCANI A, et al.: Immunization with anticardiolipin cofactor (beta 2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice. J Autoimmun 1994; 7: 441-55.
81. ARON AL, CUELLAR RL, BREY RL, MECEOWN S, ESPINOZA LR, SHOENFELD Y: Early onset of autoimmunity in MRL/++ mice following immunization with beta 2 glycoprotein I. Clin Exp Immunol 1995; 101: 68.
82. 2 GPI. Am J Reprod Immunol 1997; 37: 118-24.
83. GINSBERG JS, WELLS PS, BRILL-EDWARDS P et al.: Antiphospholipid antibodies and venous thromboembolism. Blood 1995; 86: 3685-91.
84. HORBACH DA, VOORT E, DONDERS RCJM, DERKSEN RHWM, DE GROOT F: Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Thromb Haemost 1996; 76: 916-24.
85. HARRIS EN, CHAN JKH, ASHERSON RA, ABER VR, GHARAVI AE, HUGHES GRV: Thrombosis, recurrent fetal loss and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med 1986; 146: 2153-6.
86. LOCKSHIN MD, DRUZIN ML, GOBI S, et al.: Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 1985; 313: 152-6.
87. DELEZE M, ALARCON-SEGOVIA D, VALDES-MACHO E, ORIA CV, PONCE DE LEON S: Relationship between antiphospholipid antibodies and recurrent fetal loss in patients with systemic lupus erythematosus and apparently healthy women. J Rheumatol 1989; 16: 768-72.
88. ESCHWEGE V, DARNIGE L, PIETTE JC, BOFFA MC: European Forum on the Antiphospholipid Antibodies: Report of the first meeting, October 10-11th, 1997, Hospital Saint-Louis, Paris. Lupus 1998 (in press).
89. HARRIS EN: The Second International Anti-Cardiolipin Standardization Workshop/The Kingstone Anti-Phospholipid Antibody Study (KAPS) Group. Am J Clin Pathol 1990; 94: 476-84.
90. HARRIS EN, PIERANGELI S, BIRCH D: Anticardiolipin Wet Workshop Report. Fifth International Symposium on Antiphospholipid antibodies. Am J Clin Pathol 1994; 101: 616-24.
91. TINCANI A, SPATOLA L, CATTANEO R, BALESTRIERI G: Antiphospholipid ELISA: The state of the art. Lupus 1996; 5: 477-9.
92. REBER G, ARVIEUX J, COMBY E: Multicenter evaluation of nine kits for the quantitation of anticardiolipin antibodies. Thromb Haemost 1995; 52: 444-52.
93. 2-glycoprotein I: Preparation, properties and availability to investigators. Clin Chem 1996; 42: 1116-1117.
94. BRANDT JP, TRIPLETT DA, ALVING B, SCHARRER I: Criteria for the diagnosis of lupus anticoagulants: An update. Thromb Haemost 1995; 74: 1185-90.
95. TINCANI A, BREY R, BALESTRIERI G, et al.: International survey on the management of patients with SLE. II. The result of a questionnaire regarding neuropsychiatric manifestations. Clin Exp Rheumatol 1996; 14 (Suppl. 16): 23-9.
96. MATSUURA E, IGARASHI I, FUIJMOTO M, ICHIKAWA K: Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol 1992; 148: 3885-91.
97. MARTINUZZO ME, FORASTRIERO RR, CARRERAS LO: Anti beta 2 glycoprotein I antibodies: Detection and association with thrombosis. Br J Haemathol 1995; 89: 397-402.
98. 2-glycoprotein I in patients with antiphospholipid syndrome. Br J Rheumatol 1996; 35: 1239-43.
99. ALARCON SEGOVIA D, CABRAL AR: Auto-antibodies in systemic lupus erythematosus. Curr Opin Rheumatol 1996; 8: 403-7.
100. ALARCON-SEGOVIA, D, CABRAL AR: The antiphospholipid/cofactor syndromes. J Rheumatol 1996; 23: 1319-22.
101. 2glycoprotein I assay for discrimination between anticardiolipin antibodies associated with infection and increase risk of thrombosis. Br J Haematol 1995; 21: 471-3.
102. SPATOLA L, TANZI P, TINCANI A, et al.: Antiphospholipid and anti-beta 2 glycoprotein I antibodies in patients with obstetrical complications. 7th International Symposium on Antiphospholipid Antibodies. Lupus 1996; 5: 512.
103. 2glycoprotein I antibodies are associated with some obstetrical complications, mainly preeclampsia-eclampsia. Eur J Obst Gyn Reprod Bio 1997; 73: 37-42.